6304-56-9Relevant articles and documents
Synthesis and biological activity of 1-alkyl(heteryl)-5-oxopyrrolidine-3-carboxylic acids
Gein,Silina,Cherepanov,Shishkin,Syropyatov, B. Ya.,Voronina,Varkentin
, p. 2693 - 2695 (2017/03/22)
-
INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
-
Page/Page column 161, (2010/12/29)
This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic α-synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.
Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis
He, Xin,Alian, Akram,Stroud, Robert,Ortiz De Montellano, Paul R.
, p. 6308 - 6323 (2007/10/03)
In view of the worldwide spread of multidrug resistance of Mycobacterium tuberculosis, there is an urgent need to discover antituberculosis agent with novel structures. InhA, the enoyl acyl carrier protein reductase (ENR) from M. tuberculosis, is one of t